-
Innovation Ranking
Innovation Ranking – Viscofan SA
Viscofan SA (Viscofan) is a manufacturer and distributor of casings and films for meat industry. The company’s product portfolio includes cellulose, collagen, fibrous and plastic casings. Its products are used in the production of industrial cooked sausages, fresh and processed sausages. Viscofan is also a producer and distributor of electricity. The company operates manufacturing plants in Spain, Uruguay, Mexico, Brazil, the USA, Canada, Belgium, Germany, Serbia, Czech Republic, China, Australia and New Zealand. It has electricity co-generation plants in Germany,...
-
Company Insights
Innovation and Patenting activity of Viscofan SA Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Viscofan SA Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
NewIschemic Cardiomyopathy – Drugs In Development, 2024
Empower your strategies with our Ischemic Cardiomyopathy – Drugs In Development, 2024 report and make more profitable business decisions. Ischemic cardiomyopathy is a type of cardiomyopathy caused by a narrowing of the coronary arteries that supply blood to the heart. Patients with ischemic cardiomyopathy often have a history of acute myocardial infarction (MI), but it may occur in patients with coronary artery disease but no past history of acute MI. This cardiomyopathy is one of the leading causes of sudden cardiac...
-
Product Insights
NewLeft Ventricular Dysfunction – Drugs In Development, 2024
Empower your strategies with our Left Ventricular Dysfunction – Drugs In Development, 2024 report and make more profitable business decisions. Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heart beat, and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism, and coronary artery disease. The Left Ventricular Dysfunction drugs in development market research report provide comprehensive information on the therapeutics under development for Left Ventricular Dysfunction,...
-
Product Insights
NewCardiomyopathy – Drugs In Development, 2024
Empower your strategies with our Cardiomyopathy – Drugs In Development, 2024 report and make more profitable business decisions. Cardiomyopathy a disease of the heart muscle, where the walls of the heart chambers have become stretched, thickened or stiff. This affects the heart's ability to pump blood around the body. Most types of cardiomyopathy are inherited. It can also be caused by other conditions, or risk factors, but for some people the cause is unknown. Cardiomyopathy can affect people of all ages...
-
Product Insights
Viscofan USA – Danville Manufacturing Plant Expansion – Illinois
Equip yourself with the essential tools needed to make informed and profitable decisions with our Viscofan USA - Danville Manufacturing Plant Expansion - Illinois report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Company Profile
Viscofan SA – Company Profile
Viscofan SA (Viscofan) is a manufacturer and distributor of casings and films for meat industry. The company’s product portfolio includes cellulose, collagen, fibrous and plastic casings. Its products are used in the production of industrial cooked sausages, fresh and processed sausages. Viscofan is also a producer and distributor of electricity. The company operates manufacturing plants in Spain, Uruguay, Mexico, Brazil, the USA, Canada, Belgium, Germany, Serbia, Czech Republic, China, Australia and New Zealand. It has electricity co-generation plants in Germany,...
Add to Basket -
Track & Monitor
Innovation in Automotive: Extrusion moulded parts
Innovation in the automotive industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in automotive industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...
-
Product Insights
Congestive Heart Failure (Heart Failure) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Congestive heart failure (heart failure) report provides comprehensive information on the therapeutics under development for Congestive Heart Failure (Heart Failure), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Congestive Heart Failure...
-
Product Insights
Left Ventricular Dysfunction Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Left ventricular dysfunction is the most common cause of congestive heart failure. Symptoms include fluid retention, dizziness, fatigue, weakness, irregular heartbeat, and congested lungs. Risk factors include high blood pressure, diabetes, sleep apnea, alcoholism, and coronary artery disease. The left ventricular dysfunction drugs in development report provides an overview of the left ventricular dysfunction pipeline landscape. It provides comprehensive information on the therapeutics under development for left ventricular dysfunction, complete with analysis by stage of development, drug target, mechanism of...